FDA Approvals - FROVA (R) Phase III Study Data Demonstrates That Short-Term Prevention
FROVA (R) Phase III Study Data Demonstrates That Short-Term Prevention Treatment Reduces Frequency and Severity of ... (RedNova)
Endo Pharmaceuticals Inc., a wholly owned subsidiary of Endo Pharmaceuticals Holdings Inc.
Indian biotech to witness more mergers, acquisitions: experts (PharmaBiz)
India is being viewed as a destination for partnerships and mergers. In the next two years, large and medium size biotech companies across the world would look to partner, merge and acquire some of their Asian counterparts and India is the strongest contender.